Edward Stelmakh - Oct 11, 2022 Form 4/A Insider Report for OptimizeRx Corp (OPRX)

Role
CFO/COO
Signature
/s/ Marion Odence-Ford, by Power of Attorney
Stock symbol
OPRX
Transactions as of
Oct 11, 2022
Transactions value $
-$53,687
Form type
4/A
Date filed
4/22/2024, 08:31 AM
Date Of Original Report
Mar 29, 2023
Previous filing
Oct 5, 2022
Next filing
Oct 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OPRX Common Stock Tax liability -$53.7K -3.54K -31.54% $15.17 7.68K Oct 11, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On March 30, 2023, the reporting person filed a Form 4 which inadvertently overstated the number of shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. As reported in this amendment, the Issuer withheld 3,539 shares to satisfy the Reporting Person's tax withholding obligations (not 6,539 shares as previously reported). Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended.
F2 As a result of the overstatement of the shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations, the Reporting Person's holdings following the reported transaction were understated by the amount of such overstatement. This inadvertent understatement has been corrected in this amended filing. This understatement also affected subsequently filed Forms 4, but will be corrected in any Forms 4 filed after the date of this amended filing.

Remarks:

The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.